{"name":"AnaptysBio, Inc.","slug":"anaptysbio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE5vVU50Q3J5WndtekRjaGY5czhqdW11NVNqQ0c1OXg4SDFFN0ZHdjhZeTBpZmNUTEM5Wld1bHlCSG9TcFV0X3B3dHE0RDk4UFU?oc=5","date":"2026-04-08","type":"pipeline","source":"MEXC Exchange","summary":"ANABV Price Today: AnaptysBio, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange","headline":"ANABV Price Today: AnaptysBio, Inc. Stock Price, Quote & Chart | MEXC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxOYzhIMDROUTVfZ1ROTEpraVhELWJDcW9oNnN2MGJpN1I1ejRPbF8yMnUwdUE3X2hOSXBUZGluRVJwdEVfZVp4SFZRSGpqSEpHNDRzSFFzazZUd09EQzBGcXV2TDR1em40TERERTEweGVtZ2lwSlE5TlhNN3cxOW5qbmI1RU53a05CYUlVYU5IR19LNXc5OUFQNjlSNDZhbnVIYmtTOWZCdF96TGtOQ2JJYm85Ym1vOE1wLTVrdzg3NWpndXp5X1RfaURPcjVnSGhVTXpvZWV0TjRVYUVJdmlJemM0ejA3Smp0d2R4T25XckY0Wmh3TDlYbC13WmYxZUxudDg2bnFoVFdjS0hMQjJHelR3cnYza0NOdWJoSFNjVFRUWmtXV1ZZ?oc=5","date":"2026-04-05","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB) - The Globe and Mail","headline":"Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (AN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxORmJNMmhaZDdQcGhQSDNaZmtBZktObzNEZ3Z4b0k2UXkwT0Zxeml2Y1JzeHFlUGs4ZGVzSWhFLUNKM3pZUzlnOTBWZGJUWGZscFBEMGZwME0xTVpmR0dhanJ2blloTkVLWl9fYk9Ra1JlZkhrWWJzdFJXbHAyS2huOTFkdXJiSGVNQzdRYTctM09EOFQ4eGN0T1hLM244ekRHYUhqX1ZLVm1GLUVncVF0SmpCbzk1UU5UbjFRdmQ0ajhfWGJoVzRvOXBR?oc=5","date":"2026-01-12","type":"deal","source":"Investing.com","summary":"Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock - Investing.com","headline":"Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPRV8wWURzSXhodF9lS0Y5aG5HN0hqNExlR3RfUzZVMWtOY3dSU2x1cXd1ZHBvY0daZG42ZjN1Z01fcGNZM0JlZ3FJYnpXc0pwYjFFbzZfWElQT1duM0dZdDhvS3lFMDVkZENuTy1nSWhLN1ZMa3FtZkZ6Ul94XzlwYzh3OE5yazFYdWJ2ZmVCY2lPcm5VU1dpWHRxM24zRENxUzFXN1FBMk5UVHBmQ21wcXM3M1J5Tmh0cDI1ZG5MN2VCX0tZc3VYQTVB?oc=5","date":"2026-01-11","type":"pipeline","source":"The Motley Fool","summary":"What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally - The Motley Fool","headline":"What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOTE96Si1fZEdCUjRpc3UtOGZ6TDZsTXlNdTJLOEJDMGxYWk9RSi1JY01RZ3dEVzNabnVLNklFc3hsSVVLdWtyY0VqQlVXQmpteDVOVmZHN0xyZFRmbzNhWGVBTHo4TFlSMjVGMWR0RUZ1YlBwWjRnNVMwRU9wbXR4ZWw0ZWw0emY2VmVvaC13My1QSkhMelV5NktMdXU2VC04NWg3SWV0SGxiS19sV3pyWVNTck5rWmRET2E2emFVaDAyOTh3MGdnR1hqSnBMX2lLU2lFUi1tSnFrRmpXVHJ5NkpoTGM?oc=5","date":"2026-01-09","type":"pipeline","source":"Reuters","summary":"AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - Reuters","headline":"AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPQ0tzNURrdzR4emk2elBjTndDaVg1Qk5OdXBsVERuQnhzV1BBaW5rWXdJVG5INWh3Y1JwY3F4VTA2Um43d1VvTlAydzdMbkxaM1B1dmlRZUVJS3N0elAyT0ZRRHRZMWpvM2hVNG1pV1NZYzlpTnB1ajFWTG9rQUtuRHN6QmxuQS1icmtRVDdnVFV4UkViOTZTc0hqQlY?oc=5","date":"2025-11-24","type":"pipeline","source":"Pharmaceutical Executive","summary":"Tesaro and AnaptysBio's Legal Battle | PharmExec - Pharmaceutical Executive","headline":"Tesaro and AnaptysBio's Legal Battle | PharmExec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQZXZwRk9oMUFleGpMNzEyNzNCQ3ZiWmhSWEhQcktrNmM0YW9NaXAxVWZROGJMNlpqbnJZeVc3WnZ0QzZlZjhnTm9KYlduc2NkMXA3SEJtOWViVDMtR1JyeW5aWXIzdEFGNVYzSXo2NFFuUDFucEZoa2FZN3J1Wm5hNG1rVWtPZzBLaUNHeUhR?oc=5","date":"2025-11-21","type":"earnings","source":"BioPharma Dive","summary":"GSK, Anaptysbio sue each other over Jemperli revenue - BioPharma Dive","headline":"GSK, Anaptysbio sue each other over Jemperli revenue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdXFHMnlpX3BabF9tZlVZLWQtWXlGdnRUb1VrSnlmNi12ZXQzUmUwck12Nm9MS1hjRkZlQzdvcjVIMGJCR3RGMEJvenRncERLRGFEd3FHQXhVYzllVFNmbXN1M2Zfd3M4MHB4aGJFTHJYdFZFQ1YzcWtkWl81eUJjQ0tNSXRlOFhCMk5uNkQ1Vnh6eVVlcWJYVHE4dHNPdmdhMi1OT2U5OE5pQWY1TEdfYXNn?oc=5","date":"2025-11-21","type":"pipeline","source":"Fierce Pharma","summary":"GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement - Fierce Pharma","headline":"GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNOFdXbkxKWDhHSUtOU1JxaGpmcVAtMm4zbnVLdklvRUhsbmUzRmFMdmphQkhIaTZRZkROYmhieDZGYzZxM2xhZU5DXy0yV0VDQjgydGRPb0FMR01XVThZNzFsd3k3OXFpaXFNQlZQMDFMWHYySWVBZzJPeVZzMGJXY2N6Z2ZTWmtudXViN2tWdi1IeU52X2lKYV9nMlZWVmd3Z1NIaDV4M3Zyc1pIb3pZUEhHOUhGYXVTYlRTQXl1M0ZOcndhWmNackdnR2M?oc=5","date":"2025-11-12","type":"pipeline","source":"San Diego Business Journal","summary":"AnaptysBio to Establish Separate Royalty Management, Pharma Development Cos. - San Diego Business Journal","headline":"AnaptysBio to Establish Separate Royalty Management, Pharma Development Cos.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOSjdicU9CeG84QmtoTDduNE52eGFyLVV3NVg2S3RYLVF0TXdKRGwzU21neGU1QzZMOGp6aEY2bFVUUUx6Y241VGxKZ0xZekpDZlRHQkZnUmZJSjVodUlLNEFTRXp4LWdTc0VuN0pGMTUyWXBaQTR1RTkxQURiVk93cUJLa2VrdXkzMWJYMGtzSWc?oc=5","date":"2025-09-30","type":"pipeline","source":"The Pharma Letter","summary":"AnaptysBio rises on plans to split company - The Pharma Letter","headline":"AnaptysBio rises on plans to split company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNMng3MzI1S081amZGVlJvQXdubmU0QjNzRDd5blhmcnFSU2ZNSUVkM084VEdGRm03OEg0YXBWc3QtWERqLXh5QVhzc3FrOFZrX2VWTHdKU1ZfcllpcTdIVGZ3UHF1MWktOVRaNG12SGNNRTVvQlljamZ6dUZfWmdLNFE0U0dsTlpVRUpBUWNyajdsTnRqaXRobFRZakplcWJOcmRJSkptdVdpUFU?oc=5","date":"2025-09-30","type":"pipeline","source":"Fierce Biotech","summary":"AnaptysBio plans to split biotech and Jemperli royalties into separate businesses - Fierce Biotech","headline":"AnaptysBio plans to split biotech and Jemperli royalties into separate businesses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNbzdpLThhazdFakFlTlJNSUxkVUYxbDRTZG1XQUtrc0JLd3pvTWttSm9acUhldllHQXJwcWNUbHEyQUJEWEdLRGMxR05vaVZTcGx6ZjFEZ0xWVTdqMnBlZktZM1lfQlRFekRpbHpKckYwUkdNM0RsSlFmbjRLbGlXQ1pQU2NZcm9PLWQ3aVdKY3VwX0FxQldpdlp0cjl2NUh4eDFXOG4wbUtadw?oc=5","date":"2025-09-30","type":"pipeline","source":"BioWorld News","summary":"A house dividing: Anaptysbio wants separate pipeline, royalty firms - BioWorld News","headline":"A house dividing: Anaptysbio wants separate pipeline, royalty firms","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}